Kaplan-Meier Type Survival Curves for COVID-19: A Health Data Based Decision-Making Tool

por Calabuig, J. M., García-Raffi, L. M., García-Valiente, A., Sánchez-Pérez, E. A.
Publicado 2021

Study of correlation between forced vital capacity and demand for healthcare services in severe asthmatics

por Castelluccio, J.F., Stirbulov, R., Perez, E.A., Oliveira, J.C.M., Donner, C.F., Oliveira, L.V.F., Rasslan, Z.
Publicado 2015

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial

por Cheng, H, Ballman, K, Vassilakopoulou, M, Dueck, A C, Reinholz, M M, Tenner, K, Gralow, J, Hudis, C, Davidson, N E, Fountzilas, G, McCullough, A E, Chen, B, Psyrri, A, Rimm, D L, Perez, E A
Publicado 2014

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) r...

por Nahleh, Z. A., Barlow, W. E., Hayes, D. F., Schott, A. F., Gralow, J. R., Sikov, W. M., Perez, E. A., Chennuru, S., Mirshahidi, H. R., Corso, S. W., Lew, D. L., Pusztai, L., Livingston, R. B., Hortobagyi, G. N.
Publicado 2016

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

por Schneider, B P, Li, L, Shen, F, Miller, K D, Radovich, M, O'Neill, A, Gray, R J, Lane, D, Flockhart, D A, Jiang, G, Wang, Z, Lai, D, Koller, D, Pratt, J H, Dang, C T, Northfelt, D, Perez, E A, Shenkier, T, Cobleigh, M, Smith, M L, Railey, E, Partridge, A, Gralow, J, Sparano, J, Davidson, N E, Foroud, T, Sledge, G W
Publicado 2014